Orphan Canada is a specialty pharmaceutical company that is committed to commercializing therapies for patients suffering from genetic and rare diseases that have no cure. Through a partnership with Bourne Partners, we provide US & European-based pharma/biotech companies with a complete Canadian commercial presence for their products; including regulatory, market development, market access, sales & marketing and product distribution.